What this video covers
A video from ARDD, posted on Oct 20, 2026. It is about measuring biological age and the science of aging. It names GLP-1 drugs.
It comes from a research institute, foundation or scientific meeting on aging. We link to it; we don't make or endorse it. Research stages on this site come from published studies, not from videos.
Measuring biological age: the research →The science of aging: the research →
From the video's description
Kevin Duffin, Eli Lilly, presents at the 13th Aging Research and Drug Discovery Meeting: Modulation of Aging Clocks by the GLP-1/GIP dual agonist, Tirzepatide Key takeaway: In a SURMOUNT-5 sub-study, 72 weeks of tirzepatide slowed multiple epigenetic clocks, including organ-specific clocks, though some methylation-based predictions missed. The Aging Research and Drug Discovery (ARDD) meeting is the world's leading conference dedicated to longevity biotechnology. It convenes top researchers, pharmaceutical executives, regulators, entrepreneurs, and investors to accelerate the translation of aging science into next-generation medicines. ARDD was founded by Alex Zhavoronkov in 2014. Following years of growth in Europe, ARDD made its North American debut in Boston at the David Rubenstein Treehouse at Harvard University on October 1-3, 2026. The conference opened with a ribbon-cutting cere…
Written by ARDD on YouTube.
More videos like this
Research institutePhilipp Gut at ARDD2026: Nutrition to slow biological aging in dogsMeasuring biological age
Research instituteDan Promislow at ARDD2026: The Companion Dog as a Translational Model of AgingRapamycin · Stage 2 of 4
Research instituteAlex Zhavoronkov at ARDD2026: Aging-first Drug Discovery with MMAI and Longevity Foundation ModelsMeasuring biological age
Research instituteKirsten Seale at ARDD2026: From Infrastructure to InsightGLP-1 drugs · Stage 4 of 4